our Mission

About US

What is Enduring Hearts?

Enduring Hearts is a curator and accelerator of research that will save the lives of kids living with a transplanted heart.

What does Enduring Hearts do?

We find the leading doctors and scientists in the field of transplanted organ rejection and capitalize their groundbreaking research. We follow the research process closely, utilizing our skills in building numerous successful businesses, we ensure that the funding is used efficiently and that our investment yields positive returns.

Why is Enduring Hearts’ work necessary?

  1. A transplant is not a cure. Within 5 years, 38.5% of children with a heart transplant may die. Another 25% may need another heart transplant. Of those who have another transplant, nearly half will not survive.
  2. Organ rejection is at the core of the problem. We need to combat rejection before, during and after the transplant procedure.
  3. Without a curator, funder, and advocate, compelling research would simply remain ideas within the brilliant minds of the physicians and scientist who desperately want to help these kids live a normal healthy life.
  4. There are many organizations that fund research aimed at repairing congenital heart defects, but we are the only organization solely dedicated to helping kids who have received or require transplanted hearts.

Who will our work help:

  1. Babies born with heart defects that cannot be surgically repaired.
  2. Kids, their moms and dads, their sisters and brothers and their grandparents all live with the anxiety knowing that their transplanted heart may fail eventually.
  3. Many kids who receive other transplanted organs will also experience organ failure due to rejection

our mission

A heart transplant is not a cure, but a bridge to life…

Atlanta-based Enduring Hearts launched in 2013 with a mission to fund research that increases the longevity of pediatric heart transplants, improves quality of life for transplant recipients, and eliminates pediatric heart diseases that may result in transplant.

Make the transplant the cure.

We work toward our mission through the following programs:

  1. Direct Research Grant Program
  2. American Heart Association (AHA) Grant-making Alignment
  3. International Society of Heart & Lung Transplantation (ISHLT) Grant-making Alignment

We give priority to clinical research projects and new emerging technologies that focus on understanding the cause, development and prevention of human transplantation diseases, including organ injury and rejection, viral infection and late graft deterioration.

Enduring Hearts Board President Ankur Chatterjee’s interview on the Top Docs Radio Show (click play below to listen):


our team

Enduring Hearts’ Leadership & Board

Enduring Hearts is governed by the following body of independent professionals in addition to advisement from our Scientific Advisory Committee. Together, we are spurring the momentum of Enduring Hearts to rapidly make a significant impact, at a time when opportunities to advance transplantation science is greater than ever. Our Board of Directors continues to demonstrate a commitment to governance, fundraising, grant-making and establishing partnerships with leading institutions to achieve long-term success.

  • Patrick Gahan – Founder, Chairman & Treasurer, Enduring Hearts, Family Advocate
  • Ankur Chatterjee – President & Executive Director, Enduring Hearts
  • Carolyn Salvador- Executive Director
  • Avi Yashchin – Business Development Advisor, IBM Watson
  • Derek Cunningham – CEO, U.S. Strategic Capital
  • Lisa Kolb – Managing Partner, Alder Group
  • Scott Smith – Portfolio Manager, Morgan Stanley Wealth Management
  • Stephen Ochs – Proprietor, Fetch Park & Ice House
  • Ronald Herman – President & CEO, Sionic Mobile Corporation
  • Jennifer Kjellgren – Founder & CEO, Intown Expert Realty
  • Alok Gupta – Managing Director, Co-Founder, Loki Equity Ventures
  • Jim Marino – General Partner, Alder Opportunity Fund, LP
  • Kelley Gray – Family Advocate and Board Member
  • Audrey Callahan – Family Advocate and Board Member
  • Keely Funkhouser, Co-Founder, RollRR, Family Advocate and Board Member
  • John Hawkins, CTO, Modern Law, LLC
  • Tim Fechalos-Senior Director, Georgia Pacific

Scientific Advisory Board

Enduring Hearts occupies a unique position to make an impact with our funded projects, focused on clinically relevant research. Through the thoughtful work by our Scientific Advisory Committee, Enduring Hearts provides an excellent opportunity for young, as well as established researchers, to explore promising new ideas.

  • George T. Nicholson, M.D.
    Monroe Carell Jr. Children’s Hospital
    Assistant Professor of Pediatrics, Thomas P. Graham Jr. Division of Cardiology
    Vanderbilt University
    Nashville, Tennessee
  • Shriprasad Deshpande, M.D.
    Children’s Healthcare of Atlanta
    Pediatric Cardiologist – Sibley Heart Center
    Assistant Professor of Pediatrics – Emory University
    Atlanta, Georgia
  • Janet N. Scheel, M.D.
    Children’s National Medical Center
    Medical Director Pediatric Heart Transplant Program
    Washington, D.C.
  • Kurt R. Schumacher, M.D.
    Pediatric Cardiologist – C.S. Mott Children’s Hospital
    Assistant Professor of Pediatrics – University of Michigan
    Ann Arbor, Michigan

Enduring Hearts’ Scientific Advisory Committee makes grant selections based on areas of scientific interest (listed below in order of priority).

  1. Technology Application – Development of new technologies or applications that would improve the care of transplant patients, and thereby impact outcomes.
  2. Transplant Immunology – Research and development of novel immunotherapies, identification of novel targets, improving the side-effect profiles of these agents, as well as better monitoring and measurement of immunosuppression.
  3. Organ Matching – Strategies and innovations that would allow better organ matching and allocation.
  4. Nutrition and Exercise Physiology – Strategies and Studies aimed at development of new nutrition and exercise guidelines that improve the long-term outcomes of solid organ transplant recipients.
  5. Medication Compliance – Strategies to improve medication compliance, especially in adolescent patients and young adults.
  6. Education – Improving patient and family education, related to transplantation.

Enduring Hearts is a nonprofit, aligned with the American Heart Association. We are confident that our granting efforts will achieve our mission for stronger hearts, and longer lives.